Bristol-Myers Squibb Company News Headlines

BMY 
$58.52
*  
0.35
0.59%
Get BMY Alerts
*Delayed - data as of Nov. 25, 2014  -  Find a broker to begin trading BMY now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Bristol-Myers Signs Option Deal to Acquire Galecto Biotech - Analyst Blog
11/4/2014 5:30:00 PM - Zacks.com


GALE''s Present & Future, HNSN, CSII Products Get CE Mark, EBIO On Track
11/4/2014 12:37:00 AM - RTT News


Abbvie Inc. Trading At A Deep Discount, But With Risks
11/3/2014 11:00:00 AM - Seeking Alpha


Bristol-Myers Squibb Gets Option To Buy Galecto Biotech - Quick Facts
11/3/2014 8:52:00 AM - RTT News


GlaxoSmithKline: Why I Bought Shares Of This High-Yield Health Care Stock
10/31/2014 5:00:00 PM - Seeking Alpha


Bristol-Myers Squibb Up on Positive Opdivo Phase II Study - Analyst Blog
10/31/2014 3:46:00 PM - Zacks.com


Cramer on the Stock Market: Find the Best of Best-of-Breed Stocks
10/31/2014 10:54:00 AM - TheStreet


AbbVie Q3 Earnings Top on Humira Sales, Boosts Outlook - Analyst Blog
10/31/2014 9:33:00 AM - Zacks.com


Bristol-Myers Squibb (BMY) Jumps: Stock Moves Up 8.9% - Tale of the Tape
10/31/2014 8:39:00 AM - Zacks.com


Cramer's Mad Money - Charles River Labs Battles Ebola (10/30/14)
10/31/2014 5:46:00 AM - Seeking Alpha


Retirees Feeling Anxious? Take 3 Of These Pharmaceuticals, Then Call Me In The Morning
10/30/2014 9:00:00 PM - Seeking Alpha


Eli Lilly/Boehringer Ingelheim Restructure Diabetes Deal - Analyst Blog
10/30/2014 5:05:00 PM - Zacks.com


Bristol-Myers Squibb (BMY) Stock Is Gaining on Positive Phase 2 Results
10/30/2014 2:30:00 PM - TheStreet


Bristol-Myers, Lonza Expand Manufacturing Agreement
10/30/2014 2:22:00 PM - RTT News


Bristol-Myers Squibb Rises On Earnings Boost
10/30/2014 1:06:16 PM - Trefis


Charles River (CRL) Beats on Q3 Earnings, Guidance Upped - Analyst Blog
10/30/2014 11:30:00 AM - Zacks.com


5 Things Bristol-Myers Squibb Co.'s Management Wants You to Know
10/30/2014 10:18:31 AM - Motley Fool


Bristol-Myers Squibb (BMY) Is Climbing On Phase 2 Study Results
10/30/2014 10:03:00 AM - RTT News


Bristol-Myers Squibb: Analysis Of Earnings Beat, Missed Revenues
10/29/2014 4:39:00 PM - Seeking Alpha


Will Teva (TEVA) Beat Q3 Earnings on Strong Generic Sales? - Analyst Blog
10/29/2014 4:20:00 PM - Zacks.com


InsiderInsights.com Daily Round Up 10/28/14: POL, NHF, SLB, ATI
10/29/2014 6:58:00 AM - Seeking Alpha


Bristol-Myers Squibb Strategy Could Boost Share Price
10/28/2014 12:58:00 PM - Seeking Alpha


Are XLV And The Health Care Sector Overpriced?
10/27/2014 6:09:00 PM - Seeking Alpha


Company News for October 27, 2014 - Corporate Summary
10/27/2014 9:10:00 AM - Zacks.com


How Gilead Sciences Inc. Isn't Gouging Hepatitis C Patients, in 1 Simple Infographic
10/26/2014 10:15:02 AM - Motley Fool